BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22084672)

  • 1. Treatment of Deep Vein Thrombosis with Continuous IV Infusion of LMWH: A Retrospective Study in 32 Children.
    Fiamoli V; Blatny J; Zapletal O; Kohlerova S; Janousova E
    Thrombosis; 2011; 2011():981497. PubMed ID: 22084672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of deep vein thrombosis with continuous intravenous infusion of LMWH in children--an alternative to subcutaneous application when needed.
    Blatný J; Fiamoli V
    Vnitr Lek; 2009 Mar; 55(3):227-32. PubMed ID: 19378852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.
    Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J
    Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations.
    Bellosta R; Ferrari P; Luzzani L; Carugati C; Cossu L; Talarico M; Sarcina A
    Angiology; 2007; 58(3):316-22. PubMed ID: 17626986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home versus in-patient treatment for deep vein thrombosis.
    Othieno R; Okpo E; Forster R
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD003076. PubMed ID: 29315455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated distal deep vein thrombosis: efficacy and safety of a protocol of treatment. Treatment of Isolated Calf Thrombosis (TICT) Study.
    Parisi R; Visonà A; Camporese G; Verlato F; Lessiani G; Antignani PL; Palareti G
    Int Angiol; 2009 Feb; 28(1):68-72. PubMed ID: 19190559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of use of low-molecular-weight heparin in pediatric neurosurgical patients.
    Gonda DD; Fridley J; Ryan SL; Briceño V; Lam SK; Luerssen TG; Jea A
    J Neurosurg Pediatr; 2015 Sep; 16(3):329-34. PubMed ID: 26067336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.
    Bain E; Wilson A; Tooher R; Gates S; Davis LJ; Middleton P
    Cochrane Database Syst Rev; 2014 Feb; (2):CD001689. PubMed ID: 24519568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.
    Belcaro G; Nicolaides AN; Cesarone MR; Laurora G; De Sanctis MT; Incandela L; Barsotti A; Corsi M; Vasdekis S; Christopoulos D; Lennox A; Malouf M
    Angiology; 1999 Oct; 50(10):781-7. PubMed ID: 10535716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Kearon C; Kahn SR; Agnelli G; Goldhaber S; Raskob GE; Comerota AJ
    Chest; 2008 Jun; 133(6 Suppl):454S-545S. PubMed ID: 18574272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis.
    Gonzalez-Fajardo JA; Arreba E; Castrodeza J; Perez JL; Fernandez L; Agundez I; Mateo AM; Carrera S; Gutiérrez V; Vaquero C
    J Vasc Surg; 1999 Aug; 30(2):283-92. PubMed ID: 10436448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: outcome of therapy and health economy aspects.
    Hull RD; Pineo GF; Raskob GE
    Haemostasis; 1998; 28 Suppl 3():8-16. PubMed ID: 10069757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life in Patients With Cancer Under Prolonged Anticoagulation for High-Risk Deep Vein Thrombosis: a Long-Term Follow-Up.
    Napolitano M; Mansueto MF; Raso S; Siragusa S
    Clin Appl Thromb Hemost; 2020; 26():1076029620918290. PubMed ID: 32271622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study.
    Donadini MP; Dentali F; Pegoraro S; Pomero F; Brignone C; Guasti L; Steidl L; Ageno W
    Vasc Med; 2017 Dec; 22(6):518-524. PubMed ID: 28732457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could deep vein thrombosis be safely treated at home?
    Labas P; Ohradka B; Cambal M
    Bratisl Lek Listy; 2001; 102(10):458-61. PubMed ID: 11802292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism.
    Chai-Adisaksopha C; Iorio A; Crowther MA; de Miguel J; Salgado E; Zdraveska M; Fernández-Capitán C; Nieto JA; Barillari G; Bertoletti L; Monreal M;
    Am J Med; 2018 Apr; 131(4):430-437. PubMed ID: 29274307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.